Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Short-term Investments (2022 - 2025)

Biofrontera has reported Short-term Investments over the past 4 years, most recently at $9000.0 for Q4 2025.

  • Quarterly results put Short-term Investments at $9000.0 for Q4 2025, up 28.57% from a year ago — trailing twelve months through Dec 2025 was $9000.0 (up 28.57% YoY), and the annual figure for FY2025 was $9000.0, up 28.57%.
  • Short-term Investments for Q4 2025 was $9000.0 at Biofrontera, down from $10000.0 in the prior quarter.
  • Over the last five years, Short-term Investments for BFRIW hit a ceiling of $10.5 million in Q4 2022 and a floor of $7000.0 in Q4 2024.
  • Median Short-term Investments over the past 4 years was $10000.0 (2024), compared with a mean of $1.8 million.
  • Biggest five-year swings in Short-term Investments: tumbled 99.76% in 2024 and later rose 28.57% in 2025.
  • Biofrontera's Short-term Investments stood at $10.5 million in 2022, then crashed by 99.26% to $78000.0 in 2023, then tumbled by 91.03% to $7000.0 in 2024, then rose by 28.57% to $9000.0 in 2025.
  • The last three reported values for Short-term Investments were $9000.0 (Q4 2025), $10000.0 (Q3 2025), and $9000.0 (Q2 2025) per Business Quant data.